A study by two Canadian researchers says US drug companiesspend nearly twice as much on promoting their products ($57.5 billion in 2004)than they spend on research and development ($31.5 billion in 2004). PhRMAcalled the contention a “myth.”
From the March 01, 2008 Issue of MM+M - Medical Marketing and Media